Gene therapy for liver tumours

Advances in Experimental Medicine and Biology

Volumn 465, Issue , 2000, Pages 193-205

  Mitry, Ragai R ^a   Mansour, Marc R ^a   Havlik, Roman ^a   Habib, Nagy A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTISENSE OLIGONUCLEOTIDE; B7 ANTIGEN; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 2; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; PLASMID DNA; PROTEIN P53; SOMATOMEDIN C; TELOMERASE; THYMIDINE KINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; APOPTOSIS; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE THERAPY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER METASTASIS; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE NEU; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RAT; RETROVIRUS; REVIEW; SUICIDE GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DRUG ADMINISTRATION ROUTES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LIVER NEOPLASMS;

ADENOVIRIDAE; ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0034478245     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Hepatocellular carcinoma: Non-surgical treatment
2. Prospects for human gene therapy
3. p53 Gene therapy in a rat model of hepatocellular carcinoma: Intra-arterial delivery of recombinant adenovirus
4. Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver
5. Genetic hemochromatosis: Pathogenesis, diagnosis, and therapy
6. The molecular genetics of cancer
7. Oncogenes and proto-oncogenes
8. Surgical options in the treament of hepatic metastases from colorectal cancer
9. Abnormal strusture and expression of p53 gene in human hepatocellular carcinoma
10. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
11. Hepatobiliary cancers
12. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
13. Transactivation of cellular gene expression by hepatitis B viral proteins: A possible molecular mechanism of hepatocarcinogenesis
14. Phase I study of direct administration of a replication deficient adenovirus vector containing E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine
15. New trends in the surgical treatment of colorectal cancer liver metastases
16. Sex hormonal preparations and the liver
17. Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats
18. Hepatocellular carcinoma in primary hemochromatosis in the abscence of cirrhosis
19. The p53 proto-oncogene can act as a suppressor of transformation
20. Hepatic colorectal metastasis: Current status of surgical therapy
21. The "bystander effect"; tumour regression when a fraction of the tumour mass is genetically modified
22. Pathobiological effects of hepatitis C
23. Point mutations of the p53 gene, human hepatocellular carcinoma and aflatoxins
24. Cytokines and immunotherapy
25. Hepatocellular carcinoma: Surgical treatment
26. Preliminary Report: The short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas
27. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein
28. p53 mutations in human cancers
29. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation
30. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter
31. Clinical short-term results of radiofrequency ablation in primary and secondary liver turnouts
32. Viral vector systems for gene therapy
33. Adenovirus-mediated enzyme-prodrug therapy for cancer
34. In vivo gene therapy for alpha-fetoprotein - Producing hepatocellular carcinoma by adenovirus-mediatd transfer of cytosine deaminase gene
35. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
36. Antisense approach
37. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells
38. Increased risk of death in thorotrast-exposed patients during the late follow-up period
39. The hepatitis B virus and the genesis of hepatocellular carcinoma
40. Telomerase activity in hepatocellular carcinoma and adjacent liver tissues
41. p53: Puzzle and paradigm
42. An intercalation inhibitor altering the target selectivity of DNA damaging agents: Synthesis of site-specific alflatoxin B1 adducts in a p53 mutational hotspot
43. Bystander effect caused bu cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil
44. p53, guardian of the genome
45. Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA - In vitro and in vivo studies
46. Liver metastases: Results of percutaneous ethanol injection in 14 patients
47. p53 mutations, chronic Hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
48. Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: A new alternative for an old problem
49. Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle
50. Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression
51. Curability of tumours bearing herpes thymidine kinase genes transferred by retroviral vectors
52. Tumour chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
53. Surgical resection for small hepatocellular carcinoma
54. Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells
55. Different mutations of the p53 gene in nodulein-nodule hepatocellular carcinoma as a evidence for multistage progression
56. Tissue specific expression of an anti-ras ribozyme inhibits proliferation of human malignant cells
57. Biological interactions of N-nitroso compounds: A review
58. Surgical management of hepatocellular carcinoma: Resection or transplantation?
59. retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines
60. p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells
61. Gene therapy for cancer: What have we done and where are we going?
62. Are there indications for intraarterial hepatic chemotherapy or isolated liver perfusion? The case of liver metastases from colorectal cancer
63. Antisense approach
64. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
65. Alcohol and cancer
66. Treatment of metastatic cancer to the liver
67. Mutation of p53 gene in hepatocellular carcinoma in Taiwan
68. Chromosome aberrations and cancer
69. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer
70. Standard postoperative monitoring of patients after resection of colon rectum cancer
71. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene
72. Tumor suppressor genes, growth factor genes, and oncogenes in Hepatitis B virus-associated hepatocellular carcinoma
73. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas
74. Concomitant expression of E.coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotxicity of 5fluorocytosine
75. Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice
76. Nonsurgical management of recurrent colorectal cancer
77. The multistep nature of cancer
78. Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis
79. Primary, hepatocellular carcinoma
80. Abrogation of p53-induced apoptosis by the hepatitis B vris X gene
81. Tumour suppressor genes
82. Carcinogenicity studies on halogenated hydrocarbons
83. Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene
84. Hepatitis C Virus Genotypes and Development of Hepatocellular Carcinoma